Travere Therapeutics, Inc. (TVTX)
42.63
-0.03
(-0.07%)
USD |
NASDAQ |
May 08, 16:00
42.63
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics EPS Diluted (Quarterly) : -0.3984 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 2.119 |
| Revolution Medicines, Inc. | -1.855 |
| ICU Medical, Inc. | -0.6373 |
| Tandem Diabetes Care, Inc. | -0.0087 |
| iRhythm Holdings, Inc. | -0.4286 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.60M |
| Revenue (Quarterly) | 127.20M |
| Total Expenses (Quarterly) | 163.80M |
| Enterprise Value | 4.030B |
| Gross Profit Margin (Quarterly) | 78.65% |
| Profit Margin (Quarterly) | -28.78% |
| Earnings Yield | -1.25% |
| Normalized Earnings Yield | -1.254 |